381 |
Adipose tissue: a source of stem cells with potential for regenerative therapies for wound healingTrevor, Lucy V., Riches-Suman, Kirsten, Mahajan, A.L., Thornton, M. Julie 31 March 2021 (has links)
Yes / Interest in adipose tissue is fast becoming a focus of research after many years of being considered as a simple connective tissue. It is becoming increasingly apparent that adipose tissue contains a number of diverse cell types, including adipose-derived stem cells (ASCs) with the potential to differentiate into a number of cell lineages, and thus has significant potential for developing therapies for regenerative medicine. Currently, there is no gold standard treatment for scars and impaired wound healing continues to be a challenge faced by clinicians worldwide. This review describes the current understanding of the origin, different types, anatomical location, and genetics of adipose tissue before discussing the properties of ASCs and their promising applications for tissue engineering, scarring, and wound healing. / The authors thank the Plastic Surgery and Burns Research Unit at the University of Bradford, Bradford, UK for financial support for LVT
|
382 |
Efeito antiobesogênico do óleo de peixe: função do tecido adiposo marrom e branco / Anti-obesity effect of fish oil: brown and white adipose tissue functionsThereza Cristina Lonzetti Bargut 24 February 2015 (has links)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / A modulação do tecido adiposo marrom (TAM) e do tecido adiposo branco (TAB) está associada à prevenção ou redução do ganho de massa corporal. O óleo de peixe possui diversos efeitos benéficos que podem estar relacionados a esses tecidos. Dessa forma, objetivou-se avaliar os efeitos antiobesogênicos de diferentes dietas hiperlipídicas com óleo de peixe na termogênese do TAM e na lipogênese e beta-oxidação do TAB. Para isso, foram utilizados camundongos machos C57BL/6, com três meses de idade, que foram divididos em quatro grupos experimentais: um que recebeu dieta standard-chow (SC, 10% kcal de lipídios) e outros três que receberam dieta hiperlipídica (HL, 50% kcal de lipídios). Obtivemos os grupos HL com banha de porco (HL-B), HL com banha de porco mais óleo de peixe (HL-B+Px) e HL com óleo de peixe (HL-Px). As dietas foram administradas por um período de oito semanas, sendo que a ingestão alimentar foi avaliada diariamente e a massa corporal, semanalmente. Na última semana de experimento, realizou-se a calorimetria indireta e o teste oral de tolerância à glicose. No sacrifício, a glicemia foi aferida, o sangue foi puncionado para obtenção do plasma e o TAM interescapular e o TAB epididimário foram dissecados e armazenados. A leptina, os triglicerídeos e a insulina foram mensurados no plasma. O índice de adiposidade e o HOMA-IR foram calculados. O TAM e o TAB foram avaliados por microscopia confocal e de luz. Realizou-se RT-qPCR e Western blot para avaliação de marcadores termogênicos, da captação e oxidação de ácidos graxos e glicose e de PPAR no TAM, e para a avaliação da lipogênese e beta-oxidação e de PPAR no TAB. Com relação aos resultados, o grupo HL-B apresentou ganho de massa corporal e elevação da adiposidade, associado com hipertrofia dos adipócitos, hiperleptinemia, hipertrigliceridemia, intolerância à glicose e resistência à insulina, reproduzindo um quadro de obesidade e síndrome metabólica. Por outro lado, a ingestão de óleo de peixe nos dois grupos (HL-B+Px e HL-Px) foi capaz de reduzir o ganho de massa corporal e a adiposidade, sem alterar a ingestão alimentar. Essa ingestão também aumentou o gasto energético dos animais, regularizou a leptina e os triglicerídeos plasmáticos, bem como a tolerância à glicose e a resistência à insulina. Esses efeitos foram associados ao aumento de marcadores termogênicos no TAM, bem como da captação e oxidação de ácidos graxos e glicose e da expressão de PPAR nesse tecido. No TAB, houve redução de marcadores da lipogênese e aumento de marcadores da beta-oxidação, juntamente com elevação na expressão de PPAR. Em conclusão, nossos resultados mostram que a ingestão de óleo de peixe tem efeitos antiobesogênicos em camundongos através da modulação benéfica do TAM e do TAB e pode, portanto, representar uma terapia auxiliar alternativa contra a obesidade e suas comorbidades. / Brown adipose tissue (BAT) and white adipose tissue (WAT) modulation is associated with prevention or reduction of body mass gain. Fish oil has several beneficial effects which can be related to these tissues. Thus, we aimed to evaluate the anti-obesity effects of different high-fat diets with fish oil on BAT thermogenesis and WAT lipogenesis and beta-oxidation. For this, we used 3-mo-old C57BL/6 male mice that were divided into four groups: one that received a standard-chow diet (SC, 10% kcal of lipids) and three that received a high-fat diet (HF, 50% kcal of lipids). We obtained the HF with lard group (HF-L), the HF with lard plus fish oil group (HF-L+FO), and the HF with fish oil group (HF-FO). Diets were administrated for eight weeks, and food intake was evaluated daily and the body mass, weekly. At the end of the experiment, we performed indirect calorimetry and an oral glucose tolerance test. At sacrifice, glycemia was assessed, the blood was punctured to obtain plasma and interscapular BAT and epididymal WAT were dissected and stored. Plasmatic leptin, triglycerides and insulin were analyzed. Adiposity index and HOMA-IR were calculated. BAT and WAT were evaluated through confocal and light microscopy. RT-qPCR and Western blot were performed for analyses of thermogenic markers, fatty acids and glucose uptake and oxidation, and PPAR in BAT, and lipogenesis, beta-oxidation and PPAR in WAT. In relation to the results, the HF-L group presented elevated body mass gain and adiposity, associated with adipocyte hypertrophy, hyperleptinemia, hypertriglyceridemia, glucose intolerance and insulin resistance, displaying a condition that simulates obesity and metabolic syndrome. On the contrary, fish oil intake in both groups (HF-L+FO and HF-FO) was able to reduce body mass gain and adiposity, without affecting food intake. It also increased energy expenditure, normalized plasmatic leptin and triglycerides as well as glucose tolerance and insulin resistance. These effects were associated with increases in thermogenic markers, in uptake and oxidation of fatty acids and glucose and in PPAR expression in BAT. In WAT, lipogenesis was reduced and beta-oxidation and PPAR expression were increased. In conclusion, our results demonstrated that fish oil intake has anti-obesity effects in mice through beneficial modulation of BAT and WAT and can, therefore, represent an auxiliary alternative therapy against obesity and its comorbidities.
|
383 |
Efeito antiobesogênico do óleo de peixe: função do tecido adiposo marrom e branco / Anti-obesity effect of fish oil: brown and white adipose tissue functionsThereza Cristina Lonzetti Bargut 24 February 2015 (has links)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / A modulação do tecido adiposo marrom (TAM) e do tecido adiposo branco (TAB) está associada à prevenção ou redução do ganho de massa corporal. O óleo de peixe possui diversos efeitos benéficos que podem estar relacionados a esses tecidos. Dessa forma, objetivou-se avaliar os efeitos antiobesogênicos de diferentes dietas hiperlipídicas com óleo de peixe na termogênese do TAM e na lipogênese e beta-oxidação do TAB. Para isso, foram utilizados camundongos machos C57BL/6, com três meses de idade, que foram divididos em quatro grupos experimentais: um que recebeu dieta standard-chow (SC, 10% kcal de lipídios) e outros três que receberam dieta hiperlipídica (HL, 50% kcal de lipídios). Obtivemos os grupos HL com banha de porco (HL-B), HL com banha de porco mais óleo de peixe (HL-B+Px) e HL com óleo de peixe (HL-Px). As dietas foram administradas por um período de oito semanas, sendo que a ingestão alimentar foi avaliada diariamente e a massa corporal, semanalmente. Na última semana de experimento, realizou-se a calorimetria indireta e o teste oral de tolerância à glicose. No sacrifício, a glicemia foi aferida, o sangue foi puncionado para obtenção do plasma e o TAM interescapular e o TAB epididimário foram dissecados e armazenados. A leptina, os triglicerídeos e a insulina foram mensurados no plasma. O índice de adiposidade e o HOMA-IR foram calculados. O TAM e o TAB foram avaliados por microscopia confocal e de luz. Realizou-se RT-qPCR e Western blot para avaliação de marcadores termogênicos, da captação e oxidação de ácidos graxos e glicose e de PPAR no TAM, e para a avaliação da lipogênese e beta-oxidação e de PPAR no TAB. Com relação aos resultados, o grupo HL-B apresentou ganho de massa corporal e elevação da adiposidade, associado com hipertrofia dos adipócitos, hiperleptinemia, hipertrigliceridemia, intolerância à glicose e resistência à insulina, reproduzindo um quadro de obesidade e síndrome metabólica. Por outro lado, a ingestão de óleo de peixe nos dois grupos (HL-B+Px e HL-Px) foi capaz de reduzir o ganho de massa corporal e a adiposidade, sem alterar a ingestão alimentar. Essa ingestão também aumentou o gasto energético dos animais, regularizou a leptina e os triglicerídeos plasmáticos, bem como a tolerância à glicose e a resistência à insulina. Esses efeitos foram associados ao aumento de marcadores termogênicos no TAM, bem como da captação e oxidação de ácidos graxos e glicose e da expressão de PPAR nesse tecido. No TAB, houve redução de marcadores da lipogênese e aumento de marcadores da beta-oxidação, juntamente com elevação na expressão de PPAR. Em conclusão, nossos resultados mostram que a ingestão de óleo de peixe tem efeitos antiobesogênicos em camundongos através da modulação benéfica do TAM e do TAB e pode, portanto, representar uma terapia auxiliar alternativa contra a obesidade e suas comorbidades. / Brown adipose tissue (BAT) and white adipose tissue (WAT) modulation is associated with prevention or reduction of body mass gain. Fish oil has several beneficial effects which can be related to these tissues. Thus, we aimed to evaluate the anti-obesity effects of different high-fat diets with fish oil on BAT thermogenesis and WAT lipogenesis and beta-oxidation. For this, we used 3-mo-old C57BL/6 male mice that were divided into four groups: one that received a standard-chow diet (SC, 10% kcal of lipids) and three that received a high-fat diet (HF, 50% kcal of lipids). We obtained the HF with lard group (HF-L), the HF with lard plus fish oil group (HF-L+FO), and the HF with fish oil group (HF-FO). Diets were administrated for eight weeks, and food intake was evaluated daily and the body mass, weekly. At the end of the experiment, we performed indirect calorimetry and an oral glucose tolerance test. At sacrifice, glycemia was assessed, the blood was punctured to obtain plasma and interscapular BAT and epididymal WAT were dissected and stored. Plasmatic leptin, triglycerides and insulin were analyzed. Adiposity index and HOMA-IR were calculated. BAT and WAT were evaluated through confocal and light microscopy. RT-qPCR and Western blot were performed for analyses of thermogenic markers, fatty acids and glucose uptake and oxidation, and PPAR in BAT, and lipogenesis, beta-oxidation and PPAR in WAT. In relation to the results, the HF-L group presented elevated body mass gain and adiposity, associated with adipocyte hypertrophy, hyperleptinemia, hypertriglyceridemia, glucose intolerance and insulin resistance, displaying a condition that simulates obesity and metabolic syndrome. On the contrary, fish oil intake in both groups (HF-L+FO and HF-FO) was able to reduce body mass gain and adiposity, without affecting food intake. It also increased energy expenditure, normalized plasmatic leptin and triglycerides as well as glucose tolerance and insulin resistance. These effects were associated with increases in thermogenic markers, in uptake and oxidation of fatty acids and glucose and in PPAR expression in BAT. In WAT, lipogenesis was reduced and beta-oxidation and PPAR expression were increased. In conclusion, our results demonstrated that fish oil intake has anti-obesity effects in mice through beneficial modulation of BAT and WAT and can, therefore, represent an auxiliary alternative therapy against obesity and its comorbidities.
|
384 |
Úloha tukové tkáně v rozvoji inzulinorezistence a dalších metabolických změn u nemocných s feochromocytomem / The role adipose tissue in development of insulin resistance and other metabolic disorders in patients with pheochromocytomaKlímová, Judita January 2021 (has links)
Pheochromocytoma and functional paraganglioma (PPGL) are rare neuroendocrine tumors characterized by catecholamines overproduction, which give a rise to disorders of glucose, lipid, and energy metabolism. The role of adipose tissue in these processes remains unclear. Our aim was to determine the gene expression profile in subcutaneous and visceral adipose tissue of patients with PPGL focusing on endocrine functions of adipose tissue, occurrence of brown (BAT) and beige adipose tissue (BeAT), all in connection with other measured metabolic and energy parameters and levels of circulating adipokines. We demonstrate signs of UCP1-dependent norepinephrine induced thermogenesis connected with overexpression of DIO2 in retroperitoneal VAT of PPGL and higher expression of key transcriptional factors of brown/beige adipogenesis, namely PPARGC1α, CEBPB and PRDM16. However, classic murine BAT or BeAT gene signature in VAT of PPGL was not detected. In subcutaneous adipose tissue (SAT) of PPGL we found signs of possible BeAT transformation, however without simultaneously undergoing UCP1-dependent thermogenesis. We also demonstrate that patients with PPGL have higher serum levels of FGF21 compared to healthy controls and these levels do not differ from obese patients. Furthermore, successful tumor removal...
|
385 |
Genetic Deficiency of CD40 in Mice Exacerbates Metabolic Manifestations of Diet-induced Obesity: A DissertationGuo, Chang-An 23 April 2013 (has links)
The past two decades have seen an explosive increase of obesity rates worldwide, with more than one billion adults overweight and 300 million of them obese. Obesity and its associated complications have become leading causes of morbidity and mortality in the United States and major contributing factors to the rising costs of national health care.
The pathophysiology of obesity and type 2 diabetes in rodents and humans is characterized by low-grade inflammation and chronic activation of immune pathways in adipose tissue and liver. The CD40 receptor and its ligand, CD40L, initiate immune cell signaling promoting inflammation, but conflicting data on CD40L-null mice confound its role in obesity-associated insulin resistance. A clear understanding of how CD40 and its ligand communicate to regulate and sustain the inflammatory environment of obesity is lacking. Here we demonstrate that CD40 receptor deficient mice on a high-fat diet display the expected decrease in hepatic cytokine levels, but paradoxically exhibit liver steatosis, insulin resistance and glucose intolerance compared with their age-matched wild-type controls. Hyperinsulinemic-euglycemic clamp studies also demonstrated insulin resistance in glucose utilization by the CD40-null mice compared with wild-type mice. In contrast to liver, visceral adipose tissue in CD40 deficient animals harbors elevated cytokine levels and infiltration of inflammatory cells, particularly macrophages and CD8+ effector T cells. In addition, ex vivo explants of epididymal adipose tissue from CD40-null mice display elevated basal and isoproterenol-stimulated lipolysis, suggesting a potential increase of lipid efflux from visceral fat to the liver.
These findings reveal that 1) CD40-null mice represent an unusual model of hepatic steatosis with reduced hepatic inflammation, and 2) CD40 unexpectedly functions in adipose tissue to attenuate the chronic inflammation associated with obesity, thereby protecting against hepatic steatosis.
|
386 |
mTORC2 Promotes Lipid Storage and Suppresses Thermogenesis in Brown Adipose Tissue in Part Through AKT-Independent Regulation of FoxO1: A DissertationHung, Chien-Min 23 October 2016 (has links)
Recent studies suggest adipose tissue plays a critical role in regulating whole body energy homeostasis in both animals and humans. In particular, activating brown adipose tissue (BAT) activity is now appreciated as a potential therapeutic strategy against obesity and metabolic disease. However, the signaling circuits that coordinate nutrient uptake and BAT function are poorly understood. Here, I investigated the role of the nutrient-sensing mTOR signaling pathway in BAT by conditionally deleting Rictor, which encodes an essential component of mTOR Complex 2 (mTORC2) either in brown adipocyte precursors or mature brown adipocytes. In general, inhibiting BAT mTORC2 reduces glucose uptake and de novo lipogenesis pathways while increases lipid uptake and oxidation pathways indicating a switch in fuel utilization. Moreover, several key thermogenic factors (Ucp1, Pgc1α, and Irf4) are elevated in Rictor-deficient BAT, resulting in enhanced thermogenesis. Accordingly, mice with mTORC2 loss in BAT are protected from HFD-induced obesity and metabolic disease at thermoneutrality. In vitro culture experiments further suggest that mTORC2 cell-autonomously regulates the BAT thermogenic program, especially Ucp1 expression, which depends on FoxO1 activity. Mechanistically, mTORC2 appears to inhibit FoxO1 by facilitating its lysine-acetylation but not through the canonical AKT-mediated phosphorylation pathway. Finally, I also provide evidence that β-adrenergic signaling which normally triggers thermogenesis also induces FoxO1 deacetylation in BAT. Based on these data, I propose a model in which mTORC2 functions in BAT as a critical signaling hub for coordinating nutrient uptake, fuel utilization, and thermogenic gene expression. These data provide a foundation for future studies into the mTORC2-FoxO1 signaling axis in different metabolic tissues and physiological conditions.
|
387 |
Omega-3 fatty acid enrichment of chicken eggs: Regulation of long chain polyunsaturated fatty acid metabolism in laying hensNeijat, Mohamed January 2016 (has links)
Eggs enriched with omega-3 polyunsaturated fatty acids (PUFA), particularly the longer chain PUFA (LCPUFA, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)) can boost human consumption of these fatty acids implicated in human health. Alpha-linolenic acid (ALA) from plant seeds/oils, primarily serve as the source of omega-3 PUFA for hens, however, the scarcity of ALA-rich plants and the limited conversion of ALA to LCPUFA are challenges for egg enrichment. Two major experiments were conducted to determine potential factors regulating egg enrichment of omega-3 LCPUFA based on detailed assessment of PUFA profiles in different lipid pools of hen tissues. In experiment 1, supplementation of graded levels of hempseed products, provided ~ 0.1 to 1.3% of ALA in the diets. Experiment 2, investigated dietary supplementation of flaxseed oil (ALA-rich) and algal DHA (preformed LCPUFA), each providing similar graded levels of total omega-3 PUFA. Both ALA-containing models demonstrated a plateau in DHA enrichment of eggs at higher ALA intakes. ALA-containing diets led to high concentrations of ALA in the triacylglycerol (TAG) fraction of eggs and plasma, and the adipose tissue of flaxseed oil-fed hens. In total phospholipid (PL), particularly the phosphatidylethanolamine (PE), the levels of EPA and ALA in the yolk were linearly associated with those in the liver. In all tissues, DHA dominated the PE pool, exhibiting a plateau with a strong inverse correlation to the ratio of ALA to EPA in the liver, suggesting limited ALA availability for egg DHA enrichment. The use of algal DHA should therefore permit further accumulation of DHA in the total PL and TAG fractions of yolk. However, enrichment via preformed DHA (at 3.36% algal product) was also limited by hepatic PL resulting in more DHA and EPA being shunted to the adipose TAG, concurrent with elevated hepatic acyl-CoA synthetase (ACSL1) expression. As a function of total omega-3 PUFA intakes (regardless of source), similar levels of stearidonic acid (SDA) and particularly EPA accumulated in liver PE. Therefore, hepatic PL regulation, possibly aimed at maintaining EPA level, may potentially be limiting the amount of ALA accumulation in the same pool, hence limiting the endogenous synthesis of DHA and subsequent enrichment in eggs. / February 2017
|
388 |
Energy flow and metabolic efficiency attributed to brown adipose tissuevon Essen, Gabriella January 2017 (has links)
The large capacity of brown adipose tissue (BAT) to expend energy as heat makes it an interesting potential player in weight regulation and other metabolic conditions. This is of particular interest as it has been recognized that adult humans possess BAT. The protein responsible for the heat production is uncoupling protein 1 (UCP1), which, as the name implies, uncouples the respiratory chain from ATP production; instead heat is produced. Cold is the strongest recruiter and activator of BAT. However, also obesogenic food has a low but nonetheless significant effect on the recruitment and activation of UCP1, although the significance of this has been discussed. In the present thesis, I have studied the effect of diet on BAT and the possibilities for it to be obesity-protective. This can be done by comparing responses in wild-type mice and in UCP1-ablated mice. Since the effect of diet on BAT is low, it is of importance to control the temperature and maintain thermoneutrality. Other confounding factors to keep in mind are differences in actual energy and composition of food and also cohort differences. When controlling all the parameters mentioned and giving the mice the same obesogenic diet, the mice possessing UCP1 compared to UCP1-ablated mice had higher energy expenditure, and lower weight gain, despite eating more. This confirms the presence of a UCP1-dependent diet-induced thermogenesis. Thus, the conclusion must be that possessing UCP1 does result in obesity protection at thermoneutrality. However, the relevance for human energy balance is still not established. / <p>At the time of the doctoral defense, the following papers were unpublished and had a status as follows: Paper 1: Manuscript. Paper 2: Manuscript. Paper 3: Manuscript.</p>
|
389 |
Identification de gènes impliqués dans le développement du tissu adipeux et caractérisation de PON3 et de son impact sur divers paramètres de production chez le porcLabrecque, Benoît January 2008 (has links)
Thèse numérisée par la Division de la gestion de documents et des archives de l'Université de Montréal.
|
390 |
Úloha receptorů spřažených s Gq proteiny v hnědých adipocytech / Role of Gq-coupled receptors in brown adipocytesČajková, Michaela January 2015 (has links)
Charles university in Prague, Pharmaceutical faculty in Hradci Králové, Department of biological and medical sciences Rheinische Friedrich-Wilhelms-University Bonn, Institute of Pharmacology and Toxicology Candidate: Michaela Čajková Supervisor: PharmDr. Miroslav Kovařík, Ph.D. Consultant: Dr. Linda Sarah Hoffmann Title of diploma thesis: Role of Gq-coupled receptors in brown adipocytes In my diploma thesis, we focused on four Gq-coupled receptors (F2R, LPHN1, α1DAR, TSHR) in brown adipocytes (BAs), which were identified in the screen as the highest expressed in immature and mature BAs. Our goal was to validate suggestion, that Thyroid stimulating hormone receptor (TSHR) plays a key role in differentiation of BAs and that F2R, LPHN1, α1D-AR might be important for BAs. In our study, we investigated gene expression of these four receptors in BAs, using analytical methodsquantitative reverse-transcriptase polymerase chain reaction (qRT-PCR) and Western blot. Results from analysis revealed, that expression of TSHR was increased in mature BAs, it means, that TSHR induce differentiation of BAs. The BAs transduced with short hairpin RNA (sh-RNA) against TSHR were less differentiated, this we proved also with Oil Red-O staining. Expression of adipocyte Protein 2 (aP2), peroxisome proliferator-activated...
|
Page generated in 0.0257 seconds